Skip to main content
. 2020 Jul 16;11(9):2389–2397. doi: 10.1111/1759-7714.13521

Figure 2.

Figure 2

(a) Combined index (CI) of osimertinib and palbociclib (Inline graphic) Measured value; (b) Inhibitory effect of osimertinib, palbociclib and combination in H1975OR cells (Inline graphic) Osimertinib, (Inline graphic) CDK4/6 inhibitor, and (Inline graphic) combination; (c) Crystal violet staining; (d, e) The bar graph shows the effect of osimertinib, palbociclib and combination on H1975OR proliferation ([c] Osi 2.5 μM, Palbociclib 1.25 μM; Combi 2:1, P < 0.05; [d] Osi 1.25 µM, Palbociclib 1.25 µM; Combi 1:1, P < 0.05).